Sugi Predict

Sugi Predict / Compounds / SCHEMBL1789145

SCHEMBL1789145

SCHEMBL1789145

O=C(NCc1ccccc1)[C@@H]1CCCN1

nearest known ligand 0.77

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 6/20 0.77
▸ HTR2B P41595 3/20 0.77
▸ USP2 O75604 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ HDAC1 Q13547 3/20 0.58
▸ CTSC P53634 1/20 0.57
▸ MC4R P32245 2/20 0.56
▸ GID4 Q8IVV7 1/20 0.55
▸ HDAC3 O15379 2/20 0.53
▸ HDAC2 Q92769 1/20 0.53
▸ HTR2A P28223 1/20 0.51
▸ DPP4 P27487 1/20 0.50
▸ CACNA1G O43497 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154669 1.00 HTR2C (0.77) HTR2CHTR2BUSP2ALDH1A1HPGD
SCHEMBL7874030 1.00 HTR2C (0.77) HTR2CHTR2BUSP2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL7607289 0.98 HTR2C (0.75) HTR2CHTR2BUSP2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL18337901 0.98 HTR2C (0.75) HTR2CHTR2BUSP2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL4368425 0.98 HTR2C (0.75) HTR2CHTR2BUSP2ALDH1A1HPGD
SCHEMBL9469301 0.95 HTR2C (0.71) HTR2CHTR2BUSP2ALDH1A1HPGD
SCHEMBL9469302 0.95 HTR2C (0.71) HTR2CHTR2BUSP2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL18337653 0.94 HTR2C (0.70) HTR2CHTR2BUSP2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL3267987 0.94 HTR2C (0.70) HTR2CHTR2BUSP2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL18337654 0.94 HTR2C (0.70) HTR2CHTR2BUSP2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758342-B1 NEW PEPTIDE ACTIVE SUBSTANCE AND PRODUCTION THEREOF BASF AG (DE) 2000-01-05 — — EP claimed
US-5864012-A OLIGOPEPTIDES AS ANTITUMOR AGENTS BASF AKTIENGESELLSCHAFT (DE) 1999-01-26 — — US claimed
EP-0758342-A1 NEW PEPTIDE ACTIVE SUBSTANCE AND PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 1997-02-19 — — EP claimed
WO-1995030691-A1 NEW PEPTIDE ACTIVE SUBSTANCE AND PRODUCTION THEREOF BASF AKTIENGESELLSCHAFT (DE) 1995-11-16 — — WO claimed
CN-117659018-A Chiral C1 symmetrical imidazole-pyridine-imidazolidinone tridentate nitrogen ligand, synthesis and application thereof 河南师范大学 2024-03-08 — — CN disclosed
US-20230133465-A1 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS ALZHEON, INC. 2023-05-04 — — US disclosed
CN-110240631-B Chiral isoindolone cyclopeptide derivative, preparation method and application thereof 哈尔滨师范大学 2023-02-17 — — CN disclosed
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute CE PHARM CO., LTD. (CN) 2020-09-01 — — US disclosed
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE CE PHARM CO., LTD. (CN) 2019-05-02 — — US disclosed
WO-2017177979-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE 中国科学院上海有机化学研究所 2017-10-19 — — WO disclosed
EP-2661433-B1 INDOLE COMPOUNDS OR ANALOGUES THEREOF USEFUL FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) NOVARTIS AG (CH) 2017-08-16 — — EP disclosed
US-8513266-B2 Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha EXELIXIS, INC. (US) 2013-08-20 — — US disclosed
US-5122604-A 2-(2-Carbonyl-substituted pyrrolidin-4-yl)carbapenems and -penems; microbiocides SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1992-06-16 — — US disclosed
EP-0272063-B1 MITOMYCIN DERIVATIVES KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1992-04-08 — — EP disclosed
US-4943569-A B-lactam compounds SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1990-07-24 — — US disclosed
US-4933333-A β-lactam compounds SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1990-06-12 — — US disclosed
EP-0346847-A2 Amino acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-12-20 — — EP disclosed
US-4863935-A Mitomycin compounds having useful anti-tumor activity KYOWA HAKKO KOGYO K.K. (JP) 1989-09-05 — — US disclosed
EP-0272063-A1 Mitomycin derivatives KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JP) 1988-06-22 — — EP disclosed
EP-0126587-A1 Carboxylic thio-pyrrolidinyl beta-lactam compounds and production thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1984-11-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133465-A1 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS PSEN2, CLN6, PSEN1 HTR2C 2815/4885HTR2B 2288/4885USP2 1445/4885
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE AOC1, AOC2, AOC3 HTR2C 1937/4885HTR2B 3092/4885USP2 1174/4885
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute AOC1, AOC2, AOC3 HTR2C 1937/4885HTR2B 3092/4885USP2 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.